Valuation : ViaDerma, Inc.

Market Cap 6.31M 5.43M 5.09M 4.65M 8.76M 603M 8.79M 60.44M 23.58M 304M 23.67M 23.16M 1.01B P/E 2015
10.7x
P/E 2016 -3.3x
Enterprise Value 6.6M 5.69M 5.33M 4.87M 9.17M 631M 9.2M 63.29M 24.69M 319M 24.79M 24.25M 1.06B EV / Sales 2015
1.5x
EV / Sales 2016 3.63x
Free-Float
99%
Yield 2015 *
-
Yield 2016 -
1 day-25.00%
1 week+200.00%
Current month+200.00%
1 month+29,900.00%
3 months-25.00%
6 months-25.00%
Current year+50.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.01
3 years 0
Extreme 1.0E-6
0.02
5 years 0
Extreme 1.0E-6
0.03
10 years 0
Extreme 1.0E-6
0.08
Manager TitleAgeSince
Chief Executive Officer - 31/03/2014
Director TitleAgeSince
Chairman - 31/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
-25.00%+200.00%-70.00%-97.30% 123K
-0.78%-1.42%+2.96%+21.65% 50.47B
-6.00%-0.75%+447.48%+535.14% 44.56B
-0.24%+0.74%+37.18%+16.26% 43.08B
-1.55%-2.07%+19.83%+71.70% 41.7B
-0.31%-0.83%+19.47%+48.24% 33.21B
-1.79%-3.24%+26.32%+125.06% 16.77B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.63%+27.62% 14.58B
-1.66%-1.25%+78.49%+42.97% 13.92B
Average -3.88%-0.95%+63.71%+87.93% 27.46B
Weighted average by Cap. -1.70%-1.06%+96.28%+129.03%

Financials

2015 2016
Net sales 192K 165K 155K 141K 266K 18.33M 267K 1.84M 717K 9.25M 720K 704K 30.68M 252K 217K 204K 186K 350K 24.08M 351K 2.42M 942K 12.16M 946K 925K 40.31M
Net income 27.12K 23.37K 21.91K 20K 37.68K 2.59M 37.8K 260K 101K 1.31M 102K 99.61K 4.34M -122K -105K -98.41K -89.83K -169K -11.64M -170K -1.17M -456K -5.88M -457K -447K -19.49M
Net Debt 288K 248K 233K 213K 400K 27.55M 402K 2.76M 1.08M 13.91M 1.08M 1.06M 46.11M 297K 256K 240K 219K 412K 28.37M 414K 2.84M 1.11M 14.32M 1.11M 1.09M 47.48M
Logo ViaDerma, Inc.
ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Employees
75
Date Price Change Volume
26/08/26 USD 0.000100 -66.67% 26,700
25/08/26 USD 0.000300 +200.00% 7,510
24/08/26 USD 0.000100 -.--% 400
  1. Stock Market
  2. Stocks
  3. VDRM Stock